Abstract:Rationale:Since the introduction of the aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA), there has been a marked increase in the reported prevalence of this condition among hypertensive, even normotensive, subjects. Patient concerns:But ARR as a spot blood draw for estimating a patient's aldosterone secretory status is influenced by many factors. Diagnoses:Here, we describe a series of patients with biochemically confirmed PA, whose diagnosis was delayed by the initial ARR assessment with non-suppressed renin. Interventions:Patient 1 had a history of resistant hypertension for many years and had a negative initial screening for secondary hypertension (including ARR). At the reevaluation, ARR was close to cutoff still with normal renin after strict and extended drug washout, and the further workup for PA demonstrated a unilateral aldosterone producing adenoma that was surgically removed, with subsequent complete biochemical remission and partial clinical success. Patient 2 was diagnosed with idiopathic hyperaldosteronism combined with obstructive sleep apnea syndrome, which could increase renin resulting in a negative ARR, and finally got a better treatment effect with PA-specific spironolactone, as well as continuous positive airway pressure. Patient 3 with hypokalemia as the main presentation was finally diagnosed with PA after excluding other diseases, and proceeded to laparoscopic adrenalectomy and histologically confirmed an aldosterone producing adenoma. Postoperatively, patient 3 achieved complete biochemical success without any medicine. Outcomes:The clinical status of all three patients was effectively managed, resulting in either complete resolution or notable improvement of their respective conditions. Lessons:After rigorous standardized diagnostic evaluation, there are still many reasons for ARR negative in PA, but they all basically occur in the background of normal or normal-high renin without suppression. A negative screening test result should be repeated and analyzed carefully if this is not consistent with the clinical picture. If, despite a repeatedly negative ARR, clinical suspicion remains high, we recommend consideration of further evaluation, including confirmatory tests and adrenal venous blood sampling (AVS) or even 68Ga-pentixafor PET/CT to better confirm the diagnosis and improve patient outcomes.

Identification of the Etiology of Primary Aldosteronism with Adrenal Vein Sampling in Patients with Equivocal Imaging Findings

Adrenal venous sampling in the diagnostic workup of primary aldosteronism

Is it Possible to Extirpate Cardiovascular Events in Primary Aldosteronism after Surgical Treatment

Segmental Adrenal Venous Sampling in Unilateral Primary Aldosteronism With Apparent Bilateral Aldosterone Suppression

Evaluation of adrenal vein anatomy by adrenal venous sampling in patients with primary aldosteronism in Chinese

Role of unilateral‐cannulating adrenal venous sampling for the subtyping of primary aldosteronism for adrenalectomy: Experience from a low‐volume center

Imaging Concordance With Vein Sampling for Primary Aldosteronism: A Cohort Study and Literature Review

Adrenal Vein Sampling for Primary Aldosteronism: Recommendations From the Australian and New Zealand Working Group

Establishment and evaluation of a predicative model in diagnosing unilateral primary aldosteronism

A comparison of the performance of 68Ga-Pentixafor PET/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism

PP.09.07

The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism

Mass spectrometry-based cortisol profiling during adrenal venous sampling reveals misdiagnosis for subtyping primary aldosteronism

Efficacy of adrenal venous sampling is increased by point of care cortisol analysis

Adrenal androgen measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism

Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice

Recent Advances in the Clinical Application of Adrenal Vein Sampling

The Vascular Surgeon's Experience with Adrenal Venous Sampling for the Diagnosis of Primary Hyperaldosteronism

Multifocal, Asymmetric Bilateral Primary Aldosteronism Cannot be Excluded by Strong Adrenal Vein Sampling Lateralization: An International Retrospective Cohort Study

Case Series: Primary Aldosteronism Diagnosed Despite Normal Screening Investigations: A Report of Three Cases

Diagnostic consistency between computed tomography and adrenal vein sampling of primary aldosteronism: leading to successful curative outcome after adrenalectomy; a retrospective study